News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
172 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17596)
Month
January (3218)
February (3391)
March (3462)
April (3660)
May (4667)
June (3468)
July (2307)
August (2524)
September (2745)
October (3357)
November (3389)
December (2298)
Day
2 (25)
3 (172)
4 (158)
5 (196)
6 (68)
9 (168)
10 (111)
11 (155)
12 (151)
13 (101)
16 (193)
17 (121)
18 (134)
19 (128)
20 (79)
23 (123)
24 (139)
25 (89)
26 (95)
27 (155)
30 (184)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
16
17
18
19
20
23
24
25
26
27
30
Press Releases
Praxis Precision Medicines announces positive topline results from the EMBOLD study in SCN2A and 8A developmental epilepsies, highlighting the disease-modifying potential of relutrigine
September 3, 2024
·
8 min read
Press Releases
Navigating Cancer Accelerates Investments to Enhance Care Management Platform for Providers and Patients
September 3, 2024
·
3 min read
Press Releases
Opthea to Participate in H.C. Wainwright 26th Global Investment Conference and Cantor 2024 Global Healthcare Conference
September 3, 2024
·
1 min read
Press Releases
NKGen Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference
September 3, 2024
·
3 min read
Press Releases
Compass Therapeutics to Participate in Upcoming Investor Events
September 3, 2024
·
1 min read
Press Releases
BioVie Announces FDA Authorization of Investigational New Drug Application for Phase 2 Trial to Evaluate Bezisterim in Long COVID
September 3, 2024
·
9 min read
Press Releases
LAVA Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
September 3, 2024
·
1 min read
Press Releases
4DMT to Participate in the 2024 Cantor Global Healthcare Conference
September 3, 2024
·
2 min read
Press Releases
Protara Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
September 3, 2024
·
1 min read
Press Releases
Evotec Announces Change in Management Board
September 3, 2024
·
4 min read
Previous
3 of 18
Next
